Dpp iv resistance

1 study on Dpp iv resistance mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2026-04-03 PubMed · preclinical animal · n preclinical

CJC-1295 outperforms hGRF(1-29) with 4-fold GH increase and 72-hour plasma presence

**CJC-1295's ability to bioconjugate to endogenous albumin in vivo after a single subcutaneous dose** fundamentally changes the pharmacokinetic calculus for GRF-based therapies — a single injection may sustain GH axis…

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.